You are here

Article Text

Article menu
Download PDFPDF
Editorial
Pirfenidone should be prescribed for patients with idiopathic pulmonary fibrosis

https://doi.org/10.1136/thoraxjnl-2011-201268

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests Consultancy fees received from GlaxoSmithKline, Intermune. Research contracts received from GlaxoSmithKline, Novartis. Lecture fees received from Boehringer Ingelheim.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles